Global 3D Protein Structure Analysis Market 2021
The global 3D protein structure analysis market was valued at $1,017 million in 2021 and is projected to reach $2,677 million by 2032, with a compound annual growth rate (CAGR) of 9.32% during the forecast period of 2022-2032. The market growth is expected to be driven by advancements in protein structure analysis equipment and increased research and development (R&D) expenditure to accelerate protein structure analysis.
The study of protein structures plays a crucial role in modern biotechnology, as it helps in molecular docking, structure-based drug design, and understanding protein function. Protein structure and interactions determine the performance of proteins, and studying their structures provides valuable insights. X-Ray crystallography is the primary method for determining protein structures at atomic resolution, although developed nations like the U.S., Germany, and the U.K. have also adopted cryo-electron microscopy and NMR spectroscopy for protein structure analysis.
|No. of Pages||
USD 1 billion in 2020
Product, End User, Region
|No. of Companies Mentioned||
Understanding protein structure is a key objective in molecular biology research, particularly when analyzing protein complexes found in biological samples. Contemporary methods such as cryo-electron microscopy (EM), small angle X-Ray scattering (SAXS), nuclear magnetic resonance (NMR) spectroscopy, and X-Ray crystallography are extensively used to study molecular structures and recognition mechanisms. Leading manufacturers like Bruker Corporation, JEOL Ltd., and Spectris plc offer equipment for 3D protein structure analysis to meet different laboratory needs.
The presence of major equipment providers has a significant impact on the market. For example, NJ Biopharmaceuticals LLC and JEOL Ltd. collaborated in April 2022 to develop innovative drug discovery platform solutions using JEOL’s 800 MHz NMR. This partnership aims to expand JEOL’s 3D protein structure analysis capabilities and product line. In August 2020, Thermo Fisher Scientific Inc. announced its initiative to connect pharmaceutical and biotechnology companies with contract research organizations (CROs) to provide cryo-electron microscopy services, facilitating access to this game-changing technology.
The demand drivers for the global 3D protein structure analysis market include technological advancements in equipment, increased R&D expenditure in drug discovery and development, and a focus on automation and miniaturization in X-Ray crystallography workflows. However, the market also faces limitations such as instrument limitations specific to 3D protein structure analysis, a shortage of qualified personnel, and the high cost and time-consuming nature of the methods involved.
The market is segmented based on various factors, including product, end user, and region.
Segmentation by Product
Segmentation by End User
Academic and Research Institute
Other End User
Segmentation by Region
The consumable segment is expected to dominate the global 3D protein structure analysis market based on product. This can be attributed to the wide availability of reagents, kits, screens, solvents, detergents, and other consumables used in various technologies for 3D protein structure analysis. As of 2021, the consumable segment held a market share of 63.07% in the global 3D protein structure analysis market. It is projected to reach $1,647 million by 2032 from $642 million in 2021, growing at a CAGR of 9.47% during the forecast period of 2022-2032. Consumables in this context refer to laboratory products that are used until they are depleted and then discarded, such as pipettes, syringes, beakers, funnels, and test tubes. Key players in the market supply reagents, modern screens for crystallization, solvents, and other consumables used in protein structure analysis techniques like X-Ray crystallography and NMR spectroscopy. The demand for consumables is high in the 3D protein structure analysis market due to their frequent use in protein structure analysis equipment.
In terms of end users, the biopharmaceutical company segment dominates the market. The increasing application of protein structure analysis in various industries, particularly pharmaceutical companies for drug development, contributes to its growth. As of 2021, the biopharmaceutical company segment held a market share of 49.60% in the global 3D protein structure analysis market. It is expected to reach $1,290 million by 2032 from $505 million in 2021, growing at a CAGR of 9.03% during the forecast period of 2022-2032. Protein structure analysis has gained significant importance in the past decade, primarily due to data analysis from techniques like X-Ray crystallography, NMR spectroscopy, cryo-EM, and SAXS. Informatics tools, such as data semantics and visual analytics, are being utilized in the industry, leading to improved research effectiveness, predictability, and collaboration among scientists. Computational software has also enhanced the performance of the biopharmaceutical industry by streamlining workflows, enabling collaborative research, advancing data interoperability, and providing visualization analytics for large datasets.
North America dominated the global market with a revenue of $395.5 million in 2021, mainly driven by the markets in the United States and Canada. Concerns regarding the quality, safety, and composition of pharmaceuticals have led to significant advancements in molecular biology and genetic engineering, thereby increasing the use of protein analysis technology. The high cost of equipment and software, however, may hinder the growth of the protein analysis market in this region. Nevertheless, increased R&D spending by pharmaceutical and biotech companies, along with government funding for proteomics research, are expected to drive the global 3D protein structure analysis market during the forecast period.
On the other hand, the Asia-Pacific (APAC) region is anticipated to exhibit the highest CAGR of 10.33% during the forecast period of 2022-2032. The APAC 3D protein structure analysis market is poised for rapid growth in the coming years. Several APAC countries, including Australia, China, India, Japan, South Korea, and Rest-of-Asia-Pacific, are actively working towards enhancing the adoption of drug discovery and development solutions in the region. The APAC region has witnessed significant growth in software-based technologies, with various initiatives promoting research and development in the field of drug discovery solutions.
The selection of the profiled companies is based on inputs acquired from primary experts, analysis of company coverage, evaluation of product portfolios, and assessment of market penetration.
Key companies profiled in this report include Bruker Corporation, JEOL Ltd., Spectris plc, Thermo Fisher Scientific Inc., Merck KGaA, Schrodinger, Inc., Molecular Dimensions, Arinax Scientific Instrumentation., Cambridge Isotope Laboratories, Inc., HAMPTON RESEARCH CORP., DNASTAR, RosettaCommons.org, Rigaku Corporation, Dassault Systemes, and Jena Bioscience GmbH.
Recent Industry Developments
JEOL Ltd. made an announcement in February 2022 regarding the development of a new cryo-electron microscope (cryo-EM) called CRYO ARM 200 II (JEM-Z200CA). This instrument is specifically designed for the analysis of proteins at the single particle level.
In November 2021, JEOL Ltd. introduced the ECZ Luminous nuclear magnetic resonance console (JNM-ECZL series). This console represents a significant advancement in spectrometer miniaturization and performance enhancement through cutting-edge digital and high-frequency technologies.
Thermo Fisher Scientific Inc. launched two revolutionary imaging filters in October 2020: the Thermo Scientific Selectris Imaging Filter and the Thermo Scientific Selectris X Imaging Filter. These filters have elevated cryo-electron microscopy (cryo-EM) to a new level by enabling users to observe proteins with true atomic resolution.
In April 2021, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific E-CFEG, a significant accessory for the Thermo Scientific Krios Cryo-TEM and the company’s latest cold field emission gun. The E-CFEG, unlike other available technologies, combines key components to achieve unprecedented levels of resolution in single particle analysis (SPA).
Key Questions Answered
What are the primary drivers, challenges, and opportunities in the global 3D protein structure analysis market, and how do they impact the industry?
What is the potential impact of technological advancements on key end users, such as biopharmaceutical companies and academic and research institutes?
What is the current market demand for 3D protein structure analysis and what is the projected future demand in the global market?
What are the key development strategies implemented by major players to maintain competitiveness in the market?
What potential entry barriers are expected for companies wishing to enter the global 3D protein structure analysis market?
How is each segment of the market expected to grow from 2022 to 2032 based on specific factors?
Who are the leading players in the global 3D protein structure analysis market, what significant offerings do they provide, and what is their expected market dominance?
Which emerging companies are predicted to have a disruptive impact in the future, and what are their key strategies for sustainable growth in the market?
Which companies are expected to be highly disruptive in the future and why?
Who are the major providers of computational software in the global 3D protein structure analysis market?
Who are the primary equipment manufacturers for various technologies utilized in 3D protein structure analysis?
What growth opportunities exist for companies within their respective regions of operation?